CompuGroup Medical Experiences Slow Start to 2025

CompuGroup Medical, a leader in e-health solutions, reported modest growth in Q1 2025 with revenues increasing by 1% to EUR 286.2 million, compared to EUR 284.6 million the previous year. Organic revenue slightly declined by 0.5%, while one-time revenues fell by 5% to EUR 68.1 million. Notably, recurring revenues saw a 2% rise, making up 76% of total revenues.

Despite increased investment in R&D, adjusted EBITDA dropped by 16% to EUR 51.1 million, with the EBITDA margin declining to 18%. The company launched new products including CGM one and CGM STELLA. Adjusted earnings per share were down to EUR 0.35, although free cash flow improved to EUR 78.3 million.

Segments showed mixed results: AIS revenues fell by 2%, while HIS and PCS segments saw growth of 5% and 3% respectively. CGM secured a finance package amounting to EUR 1.5 billion to support future growth and maintains its financial guidance for 2025.